We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

208 hedge funds and large institutions have $8.4B invested in BeOne Medicines Ltd in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 69 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.25% more ownership

Funds ownership: 3.52% → 3.77% (+0.25%)

7% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 69

5% less funds holding

Funds holding: 219 → 208 (-11)

18% less capital invested

Capital invested by funds: $10.3B → $8.4B (-$1.9B)

27% less funds holding in top 10

Funds holding in top 10: 11 → 8 (-3)

29% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 38

64% less call options, than puts

Call options by funds: $10.8M | Put options by funds: $29.9M

Holders
208
Holders Change
-11
Holders Change %
-5.02%
% of All Funds
3.27%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.13%
New
27
Increased
64
Reduced
69
Closed
38
Calls
$10.8M
Puts
$29.9M
Net Calls
-$19.1M
Net Calls Change
-$38.7M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$163M
2
BlackRock
BlackRock
New York
+$37.5M
3
UBS Group
UBS Group
Switzerland
+$12.4M
4
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
+$12.2M
5
Temasek Holdings
Temasek Holdings
Singapore
+$9.59M

Top Sellers

1
HA
HHLR Advisors
Cayman Islands
-$68M
2
Capital International Investors
Capital International Investors
California
-$62.2M
3
State Street
State Street
Massachusetts
-$59.1M
4
FFM
Fairmount Funds Management
Pennsylvania
-$51.6M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$50M
Name Holding Trade Value Shares
Change 		Change in
Stake
VanEck Associates
26
VanEck Associates
New York
$17.3M +$4.76M +20,651 +27%
Mitsubishi UFJ Trust & Banking
27
Mitsubishi UFJ Trust & Banking
Japan
$16.9M -$2.39M -10,380 -10%
BNP Paribas Asset Management
28
BNP Paribas Asset Management
France
$16.8M +$193K +837 +0.9%
Legal & General Group
29
Legal & General Group
United Kingdom
$16.6M +$2.3M +9,982 +12%
UBS Group
30
UBS Group
Switzerland
$16.1M +$12.4M +54,016 +149%
TCM
31
Tang Capital Management
California
$15.2M – – –
ZAM
32
Zeal Asset Management
Hong Kong
$13.1M -$15.3M -66,651 -48%
SEI Investments
33
SEI Investments
Pennsylvania
$12.8M +$674K +2,927 +4%
Goldman Sachs
34
Goldman Sachs
New York
$12.6M +$1.09M +4,731 +7%
CI
35
Capital International
California
$11.4M +$147K +639 +1%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$11.3M -$1.68M -7,290 -10%
Wells Fargo
37
Wells Fargo
California
$10.6M -$1.22M -5,280 -8%
Axa
38
Axa
France
$10.1M +$8.32M +36,139 +176%
EDRH
39
Edmond de Rothschild Holding
Switzerland
$10.1M +$1.38M +6,000 +12%
TAMH
40
Taikang Asset Management (HK)
Hong Kong
$9.78M – – –
Norges Bank
41
Norges Bank
Norway
$9.63M – – –
N
42
Nuveen
North Carolina
$9.49M +$7.6M +33,000 +163%
Canada Pension Plan Investment Board
43
Canada Pension Plan Investment Board
Ontario, Canada
$9.41M +$12.2M +52,800 New
TD Asset Management
44
TD Asset Management
Ontario, Canada
$9.31M +$4.04M +17,555 +51%
Canada Life
45
Canada Life
Manitoba, Canada
$9.23M -$317K -1,377 -3%
HSBC Holdings
46
HSBC Holdings
United Kingdom
$7.44M +$1.05M +4,581 +12%
Citadel Advisors
47
Citadel Advisors
Florida
$6.49M +$5.11M +22,207 +157%
Geode Capital Management
48
Geode Capital Management
Massachusetts
$6.35M -$2.14M -9,295 -21%
Wellington Management Group
49
Wellington Management Group
Massachusetts
$6.28M +$5.98M +25,947 +279%
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$5.98M +$2.59M +11,268 +51%
1
2
3 4 5

ONC Hedge Fund Activity: Q2 2023 in Review

208 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2023, worth a combined $8.4B — down 18% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of ONC and 27 opened new positions — a net loss of 11 holders — while 69 trimmed existing stakes and 64 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $163M. The largest seller was HHLR Advisors, cutting an estimated $68M.

  • 208 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2023, down from 219 in Q1 2023.
  • Funds reported $8.4B of BeOne Medicines Ltd stock for Q2 2023, down 18% quarter-over-quarter.
  • 27 funds opened new BeOne Medicines Ltd positions in Q2 2023 and 38 closed out, a net change of -11 holders.
  • The largest BeOne Medicines Ltd buyer in Q2 2023 was T. Rowe Price Associates, an estimated $163M added.
  • The largest BeOne Medicines Ltd seller in Q2 2023 was HHLR Advisors, an estimated $68M sold.

Based on aggregated 13F filings for Q2 2023.